Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) is now available.
Hansoh Pharmaceutical Group Company Limited announced a final cash dividend of HKD 0.1353 per share for the financial year ending December 31, 2024. The dividend is subject to shareholders’ approval on June 20, 2025, and will be paid on July 25, 2025. This announcement reflects the company’s stable financial performance and commitment to returning value to its shareholders, potentially strengthening its market position and investor confidence.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of a wide range of pharmaceutical products. The company is known for its innovative drug development and has a significant market presence in China.
YTD Price Performance: 38.31%
Average Trading Volume: 10,617,561
Technical Sentiment Signal: Sell
Current Market Cap: HK$142.1B
For a thorough assessment of 3692 stock, go to TipRanks’ Stock Analysis page.